All In Biotech

Free tool

FAERS Monitor: Sustol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022445 or its brand name (Sustol, Granisetron). Reports on generic versions are filed under their own applications.

Reports

8,930

Serious

8,044

90% of reports

Hospitalization

4,797

Death reported

1,558

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea1,069
  • febrile neutropenia724
  • vomiting673
  • diarrhoea665
  • pyrexia622
  • dyspnoea580
  • fatigue508
  • anaemia471
  • neutropenia461
  • off label use440
  • death346
  • general physical health deterioration346
  • pneumonia346
  • constipation343
  • decreased appetite340

Reports by year received

View as table
YearReports
2004129
2005106
200660
200774
200863
200953
2010123
2011242
2012621
2013366
2014421
2015431
2016654
2017568
2018701
2019619
2020603
2021721
2022680
2023481
2024441
2025476
2026296

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,229 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal72426.024.217,229
neutropeniaSignal4618.07.32,830
general physical health deteriorationSignal3467.16.41,799
anaemiaSignal4715.85.31,892
pyrexiaSignal6224.23.91,559
constipationSignal3433.73.3682
decreased appetiteSignal3403.53.1595
vomitingSignal6733.43.11,146
nauseaSignal1,0693.23.01,660
pneumoniaSignal3462.52.3320
diarrhoeaSignal6652.42.3574
dyspnoeaSignal5802.42.2492
fatigue5081.51.498
off label use4401.21.113
death3460.90.91

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.